Natural pharmaceuticals

Natural-based pharmaceutical products
Natural pharmaceuticals
Medicines derived from plants, minerals, or animals, usually linked to traditional knowledge, following the Nagoya Protocol. The following are key activities: aloe vera, chamomile, mangosteen, ipecacuana, and juanilama.
SectorMost major industry classification systems use sources of revenue as their basis for classifying companies into specific sectors, subsectors and industries. In order to group like companies based on their sustainability-related risks and opportunities, SASB created the Sustainable Industry Classification System® (SICS®) and the classification of sectors, subsectors and industries in the SDG Investor Platform is based on SICS.
Health Care
Medical Technology
Business Model Description

A disaggregated business model with emphasis on innovation and product seeding.

Expected Impact

Promote inclusive and profitable economic activities that can constitute dignifying income sources.

Indicative ReturnDescribes the rate of growth an investment is expected to generate within the IOA. The indicative return is identified for the IOA by establishing its Internal Rate of Return (IRR), Return of Investment (ROI) or Gross Profit Margin (GPM).
Aloe, Ipecacuana, and Mangosteen have a yield per ha of 50-100, 2,8, and 3,8 tons.
Investment TimeframeDescribes the time period in which the IOA will pay-back the invested resources. The estimate is based on asset expected lifetime as the IOA will start generating accumulated positive cash-flows.
Medium Term (5–10 years)
Market SizeDescribes the value of potential addressable market of the IOA. The market size is identified for the IOA by establishing the value in USD, identifying the Compound Annual Growth Rate (CAGR) or providing a numeric unit critical to the IOA.
In 2016 $2 M, and $1.5 M were exported of Aloe and Ipecacuana. (PROCOMER).
Average Ticket Size (USD)Describes the USD amount for a typical investment required in the IOA.
The cost depends on the species to be harvested and the desired volume.
Direct ImpactDescribes the primary SDG(s) the IOA addresses.
Good health and well-being (SDG 3)
Indirect ImpactDescribes the secondary SDG(s) the IOA addresses.
Responsible Consumption and Production (SDG 12) Decent Work and Economic Growth (SDG 8)
Sector Sources
  • BCCR (2021). Exportaciones FOB Totales por Producto. Matriz de datos. INEC (2019). Encuesta Nacional Agropecuaria 2019. SEPSA (2019). Comportamiento de la cartera de crédito para actividades agropecuarias. INEC (2015). VI Censo Nacional Agropecuario RESULTADOS GENERALES Asamblea de Costa Rica (1973). Ley general de salud Asamblea de Costa Rica (1998). Ley 7779, Ley de Uso, Manejo y Conservación de Suelos. Asamblea de Costa Rica (1997). Ley 7064, Ley de Fomento a la Producción Agropecuaria y MAG Asamblea de Costa Rica (1997). Ley de protección fitosanitaria
IOA Sources
  • PROCOMER (2017). Caracterización del sector productivo de plantas medicinales en Costa Rica. PROCOMER (2016). Oportunidades de comercialización de productos agrícolas incipientes. OCAMPO (2010). Manual de cultivo y conservacion de plantas medicinales. CEPAL (1993). CENTROAMERICA: FOMENTO DE LA PRODUCCION DE PLANTAS MEDICINALES Y SU INDUSTRIALIZACION. Meza et al (2020). USO POTENCIAL DE LA MANZANILLA MATRICARIA CHAMOMILLA L. Y EXPERIENCIAS EN NICARAGUA.